Leading European IT company invests $3 million in LogicNets

NewsGuard 100/100 Score

LogicNets, Inc., the web-based Expert Decision Support platform used for automating complex decision-making processes, announces an investment of $3 million from ICT Automatisering (Euronext: ICT:NA), a leading European IT services company headquartered in the Netherlands. The investment will be used to increase LogicNets' product development and deployment capacity. Additionally, ICT will expand its exclusive distribution rights for LogicNets to cover all of Western Europe.

LogicNets' and ICT's ongoing collaboration has led to the delivery of large-scale expert decision support applications to major healthcare, government, and industrial organizations. These include the Dutch National Pathology Registry and the Dutch national railway system (ProRail). Jos Blejie, CEO of ICT Automatisering commented: "Working with LogicNets we see a unique opportunity to expand the range and value of our services both within our traditional customer base and beyond."

LogicNets' software platform provides a visual designer that enables organizations to capture and share complex decision-making processes. "ICT is the perfect delivery partner for our platform, providing us with strategic access to major organizations along with superb technical competence to deliver in Europe. ICT's investment will ensure greater expansion of our market share in our core verticals of Medical, Technical Support, and Health & Safety both in the US and Europe." - said Jelle Ferwerda, CEO of LogicNets.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study aims to reduce bias in AI health prediction models